Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Takiron develops artificial bone:

This article was originally published in Clinica

Executive Summary

Takiron has developed an artificial bone material called Super-Fixsorb. The bioresorbable material is composed of bio- ceramic particles and poly-lactic acid. The biologically active material has a bending strength of 250-300 MPa and shearing strength of 110-150 MPa higher than cortical bone. Takiron, which is based in Osaka, Japan, says that Super-Fixsorb experiences minimal corrosion and prevents spongy bone formation because of the good strength match between the real and the artificial bone. The company plans to launch its product in 1998, reports Japan Medical Review.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT089451

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel